Table 5 Participant views on benefits and challenges of the ASM
Theme | Participant Types | |||||
|---|---|---|---|---|---|---|
| Â | Â | FGDs | IDIs | |||
|  |  | Enrolled Participants (n = 6) n (%) | Non-enrolled Participants (n = 6) n (%) | ART Providers (n = 7) n (%) | Case Managers (n = 8) n (%) | Pharmacy Personnel (n = 7) n (%) |
ASM Benefits | Cost and time savings | 5 (83) | 5 (83) | 4 (57) | 5 (63) | 5 (71) |
Fewer work disruption | 3 (50) | 2 (33) | 1 (14) | 1 (13) | 1 (14) | |
Privacy and reduced stigma | 4 (67) | 2 (33) | 2 (29) | 3 (38) | 1 (14) | |
Better adherence and improved health | 4 (67) | 0 (0) | 2 (29) | 3 (38) | 1 (14) | |
Improved quality of care | 5 (83) | 0 (0) | 6 (86) | 7 (86) | 3 (43) | |
Reduced provider workloads | 2 (33) | 1 (17) | 5 (71) | 7 (86) | 6 (86) | |
Decongested facilities | 5 (83) | 0 (0) | 1 (14) | 3 (38) | 4 (57) | |
Improved record keeping | 1 (17) | 0 (0) | 6 (86) | 2 (25) | 2 (29) | |
ASM Challenges | Medication storage | 3 (50) | 6 (100) | 3 (43) | 6 (86) | 4 (57) |
Less frequent monitoring by providers | 2 (33) | 4 (67) | 2 (29) | 1 (13) | 1 (14) | |
Increased stress for clients | 0 (0) | 5 (83) | 0 (0) | 0 (0) | 0 (0) | |
Misunderstanding ASM/Mistrust | 1 (17) | 3 (50) | 0 (0) | 0 (0) | 0 (0) | |
Medication shortage | 0 (0) | 0 (0) | 2 (29) | 6 (86) | 4 (57) | |